DuPont De Nemours (DD) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Fourth quarter 2024 sales grew 7% year-over-year to $3.1B, with double-digit organic growth in Electronics & Industrial and strong performance in water, healthcare, and medical packaging markets.
Operating EBITDA for Q4 rose 13% to $807M, with margin expanding 140 basis points to 26.1%; adjusted EPS increased 30% to $1.13.
Full-year 2024 net sales increased 3% to $12.4B, with operating EBITDA up 7% to $3.14B and adjusted EPS up 17% to $4.07; free cash flow conversion was 105%.
AI-related sales rose 30% to over $300M, and strong demand in electronics, healthcare, and water markets fueled performance.
The Electronics business separation is targeted for November 1, 2025, ahead of the initial timeline, with the Water business to be retained.
Financial highlights
Q4 2024 net sales were $3.1B, up 7% year-over-year, with 8% volume growth and a 1% price decrease; operating EBITDA was $807M (margin 26.1%, up 140 bps), and adjusted EPS was $1.13, up 30%.
Full-year 2024 net sales were $12.4B, operating EBITDA $3.14B (margin 25.4%, up 100 bps), adjusted EPS $4.07 (up 17%), and transaction-adjusted free cash flow $1.8B (105% conversion).
Q4 2024 transaction-adjusted free cash flow was $455M (96% conversion).
Q4 2024 GAAP loss from continuing operations was $(61)M; full-year GAAP income was $778M.
Q4 organic sales by segment: Electronics & Industrial +10%, Water & Protection +6%; by region: Asia Pacific +11%.
Outlook and guidance
2025 guidance: net sales $12.8–$12.9B, operating EBITDA $3.325–$3.375B, adjusted EPS $4.30–$4.40; Q1 2025 guidance: net sales ~$3.025B, operating EBITDA ~$760M, adjusted EPS ~$0.95.
Mid-single-digit organic sales growth expected for 2025, with a 1%–1.5% currency headwind.
Electronics Co-segment expected to grow 6%-7% organically in 2025; Industrials Co-segment 3%-4%.
New segment structure (ElectronicsCo and IndustrialsCo) to be reported from Q1 2025.
Latest events from DuPont De Nemours
- Board size reduced to ten after a director resignation; all other nominees remain.DD
Proxy filing15 Apr 2026 - 2025 delivered margin expansion and double-digit EPS growth; 2026 outlook strong for sales and cash flow.DD
Q4 202511 Apr 2026 - Annual meeting to vote on directors, pay, auditor, and reverse stock split amid governance focus.DD
Proxy filing10 Apr 2026 - Key proposals—director elections, pay, auditor, and reverse split—recommended for approval.DD
Proxy filing10 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and a reverse stock split.DD
Proxy filing23 Mar 2026 - Strong growth and margin gains offset by a $768M goodwill impairment charge.DD
Q1 20253 Feb 2026 - Adjusted EPS up 14% and full-year guidance raised amid electronics-driven growth.DD
Q2 20242 Feb 2026 - Q3 net sales up 4%, EBITDA up 11%, and full-year guidance raised as business separations progress.DD
Q3 202416 Jan 2026 - Proxy details director elections, CEO transition, and strong 2024 results with ESG focus.DD
Proxy Filing1 Dec 2025